CRISPR Therapeutics AG
CRSP
Market Cap$4.91B
Close$
$-3.73
106.8% downside
Current Fair Value
106.8% downsideOvervalued by 106.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.91 Billion |
|---|---|
| Enterprise Value | $4.89 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.34 |
| Beta | 1.74 |
| Outstanding Shares | 85,938,720 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.66 |
|---|---|
| PEG | -76.05 |
| Price to Sales | - |
| Price to Book Ratio | 2.62 |
| Enterprise Value to Revenue | 135.49 |
| Enterprise Value to EBIT | -10.21 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About CRISPR Therapeutics AG
CEO: Samarth Kulkarni